Circulating Tumor Cell Testing Market Leading Player 2022-28
December 21, 2022 ⚊ 1 Min read ⚊ Views 62 ⚊ BUSINESSCirculating Tumor Cell (CTC) Testing Market size was valued at USD 9.4 billion in 2021 and is expected to reach USD 16.4 billion by 2028, at a CAGR of 11.7% during the forecast period 2022-2028. Circulating Tumor Cell (CTC) Testing is a simple blood test that helps oncologists to assess the prognosis of patients with metastatic colorectal, breast, or prostate cancer.
Tags: Circulating Tumor Cell Testing Market